Andrew Komjathy insider trades

Open-market stock purchases and sales by Andrew Komjathy, Chief Commercial Officer at Astria Therapeutics, Inc, from SEC Form 4 filings since Sep 18, 2019.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +88%.

Recent trades

DateStockTradeValue
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)—
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)—
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$358K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$1.4M

Companies traded

  • ATXS Astria Therapeutics, Inc: 1 buy, last Jan 23, 2026
  • CATB Catabasis Pharmaceuticals Inc: other filings, last Jun 2, 2021

Get free alerts when Andrew Komjathy files a new trade →